Rubins Kathleen Hallisey
Transaction: 07/08/2026
OTHER
Change
+562
Price
$65.60
Filing
07/16/2026
Type
OTHER
FibroBiologics, Inc. Common Stock
FBLG • Biotechnology
$1.81
▲ +0.05 (+2.84%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$4.04M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.39Healthy liquidity · 3.61Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.81
Change2.84%
Shares Out2.23M
Market Cap$4.04M
Enterprise Value$3.53M
52W Range0.62 - 13.16
Beta1.17
P/E-0.22
P/B1.55
P/FCF-0.26
EV/EBITDA-0.20
EV/FCF-0.22
Price$1.81
Change2.84%
Shares Out2.23M
Market Cap$4.04M
Enterprise Value$3.53M
52W Range0.62 - 13.16
Beta1.17
P/E-0.22
P/B1.55
P/FCF-0.26
EV/EBITDA-0.20
EV/FCF-0.22
Earnings Yield-462.17%
FCF Yield-388.49%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.39
Current Ratio3.61
Quick Ratio3.61
Target$180.00
Target Upside9844.75%
Target Median$180.00
Target Range180.00 - 180.00
Volume3.59K
Avg Volume215.30K
EPS Surprise-0.07
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score▼
Manageable debt level · 0.39Healthy liquidity · 3.61Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
75/100
Bullish
Bullish
2
Hold
2
Bearish
0
Price Target
2026-07-31
Low
$180.00
Mean
$180.00
Median
$180.00
High
$180.00
Insider Transactions
Recent executive and insider activity
Niklas Victoria Ninon Olivia
Transaction: 06/23/2026
BUY
Change
+30,803
Price
$0.75
Filing
06/23/2026
Type
BUY
Link Matthew
Transaction: 06/23/2026
BUY
Change
+30,803
Price
$0.75
Filing
06/23/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Rubins Kathleen Hallisey | OTHER | +562 | $65.60 | 07/08/2026 | 07/16/2026 |
| Niklas Victoria Ninon Olivia | BUY | +30,803 | $0.75 | 06/23/2026 | 06/23/2026 |
| Link Matthew | BUY | +30,803 | $0.75 | 06/23/2026 | 06/23/2026 |
| Cilento Richard C. Jr. | BUY | +30,803 | $0.75 | 06/23/2026 | 06/23/2026 |
| Hoffman Robert E. | BUY | +30,803 | $0.75 | 06/23/2026 | 06/23/2026 |
| GARCIA RUBEN A | BUY | +61,607 | $1.38 | 05/04/2026 | 05/04/2026 |
| Davis Jason | BUY | +61,607 | $1.38 | 05/04/2026 | 05/04/2026 |
| Khoja Hamid | BUY | +61,607 | $1.38 | 05/04/2026 | 05/04/2026 |
| O'HEERON PETE | BUY | +92,410 | $1.38 | 05/04/2026 | 05/04/2026 |
| Khoja Hamid | BUY | +30,000 | $0.38 | 03/04/2026 | 03/05/2026 |
| O'HEERON PETE | BUY | +15,872 | $0.38 | 03/04/2026 | 03/04/2026 |
| O'HEERON PETE | BUY | +18,200 | $0.41 | 03/03/2026 | 03/04/2026 |
| O'HEERON PETE | BUY | +17,428 | $0.35 | 03/02/2026 | 03/04/2026 |
| Davis Jason | BUY | +70,000 | $0.41 | 03/02/2026 | 03/03/2026 |
| GARCIA RUBEN A | BUY | +40,000 | $0.33 | 02/27/2026 | 03/02/2026 |
| GARCIA RUBEN A | BUY | +140,000 | $0.34 | 12/11/2025 | 12/12/2025 |
| Cilento Richard C. Jr. | BUY | +22,000 | $0.87 | 06/12/2025 | 06/12/2025 |
| Coen Stacy Ann | BUY | +22,000 | $0.87 | 06/12/2025 | 06/12/2025 |
| Hoffman Robert E. | BUY | +22,000 | $0.87 | 06/12/2025 | 06/12/2025 |
| Link Matthew | BUY | +22,000 | $0.87 | 06/12/2025 | 06/12/2025 |